Ticker LaunchIPO · KTTA
Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. (KTTA) priced its initial public offering on Sep 16, 2021 at $5.00 per share, within its $5.00–$7.00 range, raising $24M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $65.3M. EF Hutton was lead-left underwriter, joined by Benchmark. McDermott Will & Emery advised the company and Sheppard Mullin advised the underwriters.
Pasithea Therapeutics Corp. is a biotechnology company focused on research and discovery of treatments for psychiatric and neurological disorders. It targets conditions such as depression, where it views current treatments as inadequate.
- Status
- IPO
- Ticker
- KTTA
- Exchange
- Nasdaq Capital Market
- Priced
- Sep 16, 2021
- IPO price
- $5.00
- Price range
- $5.00–$7.00
- Raised
- $24M
- Market cap at IPO price
- $65.3M
- First filed
- Apr 13, 2021
- Company counsel
- McDermott Will & Emery
- Underwriters' counsel
- Sheppard Mullin
- Sector
- Biotech & pharma
- Country / state
- FL
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Apr 13, 2021
- Latest amendment Sep 13, 2021
- Final prospectus (424B4) Sep 16, 2021
- All filings on EDGAR CIK 1841330
Other Biotech & pharma IPOs in 2021
- Pyxis Oncology, Inc.PYXS · Oct 8, 2021 · $168M
- Theseus Pharmaceuticals, Inc.THRX · Oct 7, 2021 · $160M
- Exscientia plcEXAI · Oct 4, 2021
- Thorne Healthtech, Inc.THRN · Sep 23, 2021 · $70M
- DICE Therapeutics, Inc.DICE · Sep 16, 2021 · $204M
- Tyra Biosciences, Inc.TYRA · Sep 15, 2021 · $172.8M